MedPath
HSA Approval

SPASMOLIV TABLET 10 mg

SIN03082P

SPASMOLIV TABLET 10 mg

SPASMOLIV TABLET 10 mg

June 6, 1989

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A03BB01

butylscopolamine

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

HYOSCINE BUTYLBROMIDE

10 mg

Hyoscine butylbromide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SPASMOLIV TABLET 10 mg - HSA Approval | MedPath